There are

Typically, patients only have 1.

Type 2 diabetes is the leading cause for developing chronic kidney disease (CKD). Since CKD is largely asymptomatic in its early stages, the only way to know how well a patient’s kidneys are/are not working now is to conduct chronic kidney disease screening, diagnosis, and prognostic testing.

Traditional CKD screening relies on eGFR testing alone.  Accurately diagnosing CKD also requires UACR testing. Together they determine whether kidney disease is present and at what stage. They do not, however, sufficiently predict which patients are at higher vs lower risk for future disease progression or kidney failure. That’s why all 3 tests are necessary.

Test 1: eGFR (a diagnostic test)

Most doctors automatically check a patient’s eGFR or estimated Glomerular Filtration Rate. The eGFR blood test will indicate how well the kidneys are functioning by measuring the kidneys’ ability to filter toxins or waste from your blood. The eGFR test can accurately measure how much blood these filters clean every minute based on a patient’s body size. If the blood is not being filtered properly, kidney disease is present and dangerous toxins will build up in the body.

Test 2: UACR (another diagnostic test)

Even if a patient has a normal eGFR, he/she could still have kidney disease that is progressing. That’s why the American Diabetes Association, the Kidney Disease Improving Global Outcomes and American Academy of Family Practitioners Guidelines recommend also checking a patient’s UACR or Urine Albumin-to-Creatinine Ratio. This UACR urine test will check for protein in the urine to identify decreased kidney function.  UACR is needed to accurately determine the stage of any kidney disease.

Test 3: kidneyintelX.dkd

If a patient with type 2 diabetes is also found to have chronic kidney disease, the risk for disease progression should also be assessed. Knowing this information early can help clinicians and patients work together to slow or mitigate disease. The kidneyintelX.dkd test, a simple blood test that stratifies risk, can be ordered with traditional blood work and does not require fasting.